Category Archives: Press Releases

Nyxoah announces full-body 1.5T and 3T MRI compatibility for the Genio® system to treat Obstructive Sleep Apnea (OSA)

| January 26, 2021 | Asianet Pakistan | 0

Mont-Saint-Guibert, Belgium – 26th January, 2021 – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the Company has received CE Mark Magnetic Resonance Imaging (MRI) conditional labeling for the current Genio® neurostimulation-based OSA […]

UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin

| January 26, 2021 | Asianet Pakistan | 0

Aplidium albicans First studies reported on antiviral drug effects against new variant mutant “U.K.” strain of SARS-CoV-2 Plitidepsin shows potent anti-viral effect in preclinical models of original SARS-CoV-2 as well as the new mutant U.K. strain, and by inhibiting a key host protein, has the potential to have antiviral activity against other future mutations and […]

UCSF QBI and Icahn School of Medicine at Mount Sinai Scientists Report New Preclinical Data Published in Science on Potential Best-in-Class COVID-19 Anti-Viral Treatment: Plitidepsin

| January 26, 2021 | Asianet Pakistan | 0

Aplidium albicans First studies reported on antiviral drug effects against new variant mutant “U.K.” strain of SARS-CoV-2 Plitidepsin shows potent anti-viral effect in preclinical models of original SARS-CoV-2 as well as the new mutant U.K. strain, and by inhibiting a key host protein, has the potential to have antiviral activity against other future mutations and […]

Five-year ILLUMENATE EU RCT and Pivotal study results confirm safety profile of Philips Stellarex .035” low-dose drug-coated balloon

| January 25, 2021 | Asianet Pakistan | 0

January 25, 2021 Two major randomized controlled trials (RCTs) show no difference in mortality between patients treated with the Philips Stellarex drug-coated balloon (DCB) and those treated with percutaneous angioplasty (PTA), the current standard of care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the […]

Samsung Bioepis Opens the New State-of-the-Art Headquarters to Accommodate Next Stage of Growth and Innovation

| January 25, 2021 | Asianet Pakistan | 0

Samsung Bioepis New Headquarters Located in Korea’s ‘Bio Cluster’ of Songdo in the Incheon Free Economic Zone (IFEZ) The 52,000-square-foot campus to become the hub of Samsung Bioepis’ drive for accelerated development of next-generation biologic medicines Includes ‘Welfare Center’ with cafeteria, in-house fitness center, and a daycare center A photo accompanying this announcement is available […]

Philips and Spanish healthcare group Vithas sign strategic agreement to incorporate Philips’ most advanced technologies into Vithas hospitals and clinics

| January 25, 2021 | Asianet Pakistan | 0

January 25, 2021 5-year alliance will provide Vithas Group with state-of-the-art diagnostic imaging, image viewing solutions, and minimally-invasive intervention technology to deliver faster and more accurate diagnosis and treatment to patients Vithas will become a ‘reference technology partner’ for Philips in Spain, giving it fast access to advances and innovations that Philips develops prior to […]

Philips and Rennes University Hospital sign 5-year technology, research and innovation partnership to advance patient care

| January 25, 2021 | Asianet Pakistan | 0

January 25, 2021 Hospital will have access to Philips’ latest technologies and informatics solutions to enhance the diagnosis, treatment, monitoring and management of patients Multi-year strategic partnership will accelerate clinical research focused on image-guided minimally-invasive therapy, neurology, intensive care units and digital pathology Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global […]

Philips delivers Q4 sales of EUR 6.0 billion, with 7% comp. sales growth; income from cont. operations increases to EUR 608 million, Adjusted EBITA margin improves 110 bps to 19.0%, and operating cash flow increases to EUR 1,305 million

| January 25, 2021 | Asianet Pakistan | 0

January 25, 2021 Fourth-quarter highlights •        Sales amounted to EUR 6.0 billion, with 7% comparable sales growth •        Comparable order intake increased 7% •        Income from continuing operations increased to EUR 608 million, compared to EUR 550 million in Q4 2019 •        Adjusted EBITA margin increased to 19.0% of sales, compared to 17.9% of sales […]

FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma

| January 25, 2021 | Asianet Pakistan | 0

SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that U.S. Food and Drug Administration (FDA) has granted toripalimab Fast Track designation for the first-line treatment of mucosal melanoma. Meanwhile, the FDA has also […]

FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma

| January 25, 2021 | Asianet Pakistan | 0

SHANGHAI, China, Jan. 25, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, announced today that U.S. Food and Drug Administration (FDA) has granted toripalimab Fast Track designation for the first-line treatment of mucosal melanoma. Meanwhile, the FDA has also […]

To Top